Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
about
Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findingsPotential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment.Smoking and increased Alzheimer's disease risk: a review of potential mechanismsCounseling athletes on the risk of chronic traumatic encephalopathyBioAge: toward a multi-determined, mechanistic account of cognitive aging.Molecular imaging of Alzheimer disease pathologySynaptic change in the posterior cingulate gyrus in the progression of Alzheimer's diseaseExecutive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.Predicting cognitive function from clinical measures of physical function and health status in older adults.Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.Tau imaging in neurodegenerative diseases.Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.Nonvascular retinal imaging markers of preclinical Alzheimer's disease.Vascular risk and FDDNP-PET influence cognitive performance.Youthful Processing Speed in Older Adults: Genetic, Biological, and Behavioral Predictors of Cognitive Processing Speed Trajectories in Aging.Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity.Talking with parents of high school football players about chronic traumatic encephalopathy: a concise summary.Amyloid imaging in Alzheimer's disease: a literature review.Amyloid-beta and depression in healthy older adults: a systematic review.Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status.Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints.Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.Healthy behavior and memory self-reports in young, middle-aged, and older adults.How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.Testosterone effect on brain metabolism in elderly patients with Alzheimer's disease: comparing two cases at different disease stages.
P2860
Q30666527-2EEAC899-BA59-4A71-B85B-E63BC02018D1Q31096423-7FAEA93F-05F3-4126-AC7D-136915A1DA0FQ33850834-F4F52125-529C-4BB8-B5F4-503AD5D16AC4Q33902721-C4017805-C911-4CB7-BE6C-EC382FE51AD0Q34064739-892CCF09-CB02-43B5-87B9-30A7FA6ED282Q34644175-D1FB3C88-77FB-468B-A15F-6445B044CF52Q34651135-6EA48CF6-1E65-495A-A2D5-26BBB1AA0349Q35035669-B68E306A-4B2A-4CF4-9A55-BBB37478D4B2Q35048396-FB8D64F4-632C-41F7-B687-44101203530CQ35143985-01B06FA2-5860-4418-9241-1636939FB3A8Q36662808-4CD9FCA0-0720-4DF9-89F6-A0B62839B18BQ36834567-6EBFDBFF-E9FE-44AB-A215-85438AFB8BDAQ36944895-D9C73962-21D0-4272-8C9F-2D07426C3797Q37363628-CBAEDCB0-0D52-48D1-9398-D128EF53F460Q37417513-7AFA0F55-BDC6-4F5D-8E55-C38B951CC8CEQ37691974-0DB5E6EF-48ED-432D-B4BD-08E567628EBBQ38086422-A4DC1F8C-6896-4A83-B568-E00EE12981BEQ38218390-E6E5A775-2CD4-4BFC-AEA8-D06C382F007DQ38250091-824E92D1-48C4-4E30-8420-590ADE1E589EQ38270148-2EC20E33-1A2A-46B0-A1D3-C7A496B9ACD8Q38413816-EFBDD1A7-A3A4-4331-9ABA-8BE0D9E7E4D0Q38719665-0C0A0BDF-C9C2-4B23-870E-CF6B5BC751ABQ40547789-56B5425E-24EA-4060-B475-6E9C0208A726Q40968719-04D0778E-952F-4ABF-91F9-4C41C7DA45CAQ44901723-CB1316D8-040B-484C-A056-5560667642A6Q46709675-DD175479-580F-49CB-80E8-C59824444C42Q48503003-8C9FB160-6579-46D9-B525-E9EB96D4564EQ53452091-5D055324-14F7-4B63-BB50-460A19B07DA4
P2860
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
@ast
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
@en
type
label
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
@ast
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
@en
prefLabel
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
@ast
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
@en
P2093
P2860
P1433
P1476
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
@en
P2093
Alison C Burggren
Gary W Small
Helen Lavretsky
Jeanne Kim
Jorge R Barrio
Karen J Miller
Linda M Ercoli
Prabha Siddarth
Susan Y Bookheimer
P2860
P304
P356
10.1001/ARCHNEUROL.2011.559
P577
2012-02-01T00:00:00Z